Prostaglandin E receptor subtype EP3 in conjunctival epithelium regulates late-phase reaction of experimental allergic conjunctivitis  Mayumi Ueta, MD,

Slides:



Advertisements
Similar presentations
Maria B. Sukkar, PhD, Shaoping Xie, PhD, Nadia M
Advertisements

Repeated low-dose intradermal allergen injection suppresses allergen-induced cutaneous late responses  Giuseppina Rotiroti, MD, Mohamed Shamji, PhD, Stephen.
Innate lymphoid cells contribute to allergic airway disease exacerbation by obesity  Laetitia Everaere, PhD, Saliha Ait-Yahia, PhD, Olivier Molendi-Coste,
Loss of sirtuin 1 (SIRT1) disrupts skin barrier integrity and sensitizes mice to epicutaneous allergen challenge  Mei Ming, PhD, Baozhong Zhao, PhD, Christopher.
Doxycycline reduces airway inflammation and hyperresponsiveness in a murine model of toluene diisocyanate–induced asthma  Kyung S. Lee, MS, Sun M. Jin,
Platelets play important roles in the late phase of the immediate hypersensitivity reaction  Risa Tamagawa-Mineoka, MD, PhD, Norito Katoh, MD, PhD, Saburo.
Weiguo Chen, PhD, Umasundari Sivaprasad, PhD, Aaron M
Effective prevention and therapy of experimental allergic asthma using a GATA-3– specific DNAzyme  Serdar Sel, MD, Michael Wegmann, PhD, Tanja Dicke, MSc,
Epistatic interaction between Toll-like receptor 3 (TLR3) and prostaglandin E receptor 3 (PTGER3) genes  Mayumi Ueta, MD, PhD, Gen Tamiya, PhD, Katsushi.
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Clemens Feistritzer, MD, Birgit A. Mosheimer, MD, Daniel H
A novel allergen-specific therapy for allergy using CD40-silenced dendritic cells  Motohiko Suzuki, MD, PhD, Xiufen Zheng, PhD, Xusheng Zhang, MD, PhD,
Cigarette smoke extract induces thymic stromal lymphopoietin expression, leading to TH2-type immune responses and airway inflammation  Yuki Nakamura,
Nazanin Farhadi, MSc, Laura Lambert, BA, Chiara Triulzi, PhD, Peter J
FcεRI-mediated amphiregulin production by human mast cells increases mucin gene expression in epithelial cells  Shigeru Okumura, DDS, PhD, Hironori Sagara,
IL-33 dysregulates regulatory T cells and impairs established immunologic tolerance in the lungs  Chien-Chang Chen, PhD, Takao Kobayashi, PhD, Koji Iijima,
Leukocyte nicotinamide adenine dinucleotide phosphate-reduced oxidase is required for isocyanate-induced lung inflammation  Si-Yen Liu, PhD, Wei-Zhi Wang,
Is 9 more than 2 also in allergic airway inflammation?
CD4+CD25+ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling  Jennifer Kearley, PhD, Douglas S. Robinson,
Cheng-Chiu Huang, PhD, Yu Shin Kim, PhD, William P
Toll-like receptor 3 enhances late-phase reaction of experimental allergic conjunctivitis  Mayumi Ueta, MD, PhD, Satoshi Uematsu, MD, PhD, Shizuo Akira,
Overexpression of sirtuin 6 suppresses allergic airway inflammation through deacetylation of GATA3  Hyun-Young Jang, PhD, Suna Gu, MS, Sang-Myeong Lee,
Culture medium from TNF-α–stimulated mesenchymal stem cells attenuates allergic conjunctivitis through multiple antiallergic mechanisms  Wenru Su, MD,
Critical role of IgE-dependent mast cell activation in a murine model of allergic conjunctivitis  Ken Fukuda, MD, PhD, Masaharu Ohbayashi, PhD, Kei Morohoshi,
Merritt L. Fajt, MD, Stacy L
The usefulness of measuring tear periostin for the diagnosis and management of ocular allergic diseases  Hiroshi Fujishima, MD, Naoko Okada, PhD, Kenji.
Prostaglandin E2 suppresses allergic sensitization and lung inflammation by targeting the E prostanoid 2 receptor on T cells  Zbigniew Zasłona, PhD, Katsuhide.
Corticosteroid-resistant asthma is associated with classical antimicrobial activation of airway macrophages  Elena Goleva, PhD, Pia J. Hauk, MD, Clifton.
Potentiation of IL-19 expression in airway epithelia by IL-17A and IL-4/IL-13: Important implications in asthma  Fei Huang, PhD, Shinichiro Wachi, PhD,
Janus kinase 1/3 signaling pathways are key initiators of TH2 differentiation and lung allergic responses  Shigeru Ashino, PhD, Katsuyuki Takeda, MD,
Jesús Merayo-Lloves, MD, Tong Z. Zhao, MD, James E. Dutt, BA, C
Antiviral activity of human β-defensin 3 against vaccinia virus
Reciprocal interaction of the conjunctiva and cornea in ocular allergy
Peanut-induced intestinal allergy is mediated through a mast cell–IgE–FcεRI–IL-13 pathway  Meiqin Wang, MD, PhD, Katsuyuki Takeda, MD, PhD, Yoshiki Shiraishi,
Cold temperature induces mucin hypersecretion from normal human bronchial epithelial cells in vitro through a transient receptor potential melastatin.
Toll-like receptor 2 is important for the TH1 response to cutaneous sensitization  Haoli Jin, MD, PhD, Lalit Kumar, PhD, Clinton Mathias, PhD, David Zurakowski,
A novel allergen-specific therapy with CD40-silenced B cells and dendritic cells  Motohiko Suzuki, MD, PhD, Makoto Yokota, MD, PhD, Yoshihisa Nakamura,
Prostaglandin E2 suppresses allergic sensitization and lung inflammation by targeting the E prostanoid 2 receptor on T cells  Zbigniew Zasłona, PhD, Katsuhide.
Prostaglandin E2 suppresses staphylococcal enterotoxin–induced eosinophilia- associated cellular responses dominantly through an E-prostanoid 2–mediated.
Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation  Leif Bjermer, MD  Journal of Allergy.
Src homology 2 domain–containing inositol 5-phosphatase 1 deficiency leads to a spontaneous allergic inflammation in the murine lung  Sun-Young Oh, PhD,
Baricitinib treatment in a patient with a gain-of-function mutation in signal transducer and activator of transcription 1 (STAT1)  Kornvalee Meesilpavikkai,
Cysteinyl leukotriene upregulates IL-11 expression in allergic airway disease of mice  Kyung Sun Lee, PhD, So Ri Kim, MD, PhD, Hee Sun Park, MD, PhD, Seoung.
Oral administration of a synthetic agonist of Toll-like receptor 9 potently modulates peanut-induced allergy in mice  Fu-Gang Zhu, PhD, Ekambar R. Kandimalla,
Update on the role of prostaglandins in allergic lung inflammation: Separating friends from foes, harder than you might think  Martin L. Moore, PhD, R.
Effect of ingested H1 antihistamines on methacholine challenge
Josée Lamoureux, PhD, Jana Stankova, PhD, Marek Rola-Pleszczynski, MD 
IL-12 affects Dermatophagoides farinae–induced IL-4 production by T cells from pediatric patients with mite-sensitive asthma  Takeshi Noma, MD, PhD, Izumi.
Allergen-specific sublingual immunotherapy is dose and duration dependent in a murine allergic rhinitis model  Soichi Tofukuji, PhD, Kazufumi Katayama,
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
Topical cyclosporine prevents seasonal recurrences of vernal keratoconjunctivitis in a randomized, double-masked, controlled 2-year study  Alessandro.
Duy Pham, PhD, Sarita Sehra, PhD, Xin Sun, PhD, Mark H. Kaplan, PhD 
Short ragweed pollen triggers allergic inflammation through Toll-like receptor 4– dependent thymic stromal lymphopoietin/OX40 ligand/OX40 signaling pathways 
The steroidogenic enzyme Cyp11a1 is essential for development of peanut-induced intestinal anaphylaxis  Meiqin Wang, MD, PhD, Julita Ramirez, DVM, PhD,
Physiologic assessment of allergic rhinitis in mice: Role of the high-affinity IgE receptor (FcɛRI)  Satoko Miyahara, MD, PhD, Nobuaki Miyahara, MD, PhD,
Jenny Seltmann, PhD, Lennart M
Unique and overlapping gene expression patterns driven by IL-4 and IL-13 in the mouse lung  Christina C. Lewis, PhD, Bruce Aronow, PhD, John Hutton, MD,
CCL17/thymus and activation-regulated chemokine induces calcitonin gene–related peptide in human airway epithelial cells through CCR4  Kandace Bonner,
Inhibition of allergic airways inflammation and airway hyperresponsiveness in mice by dexamethasone: Role of eosinophils, IL-5, eotaxin, and IL-13  Seok-Yong.
Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma
Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity  James N. Francis, PhD, Louisa.
Zhenying Nie, PhD, Cole S. Nelson, PhD, David B. Jacoby, MD, Allison D
MicroRNA-155 is essential for TH2-mediated allergen-induced eosinophilic inflammation in the lung  Carina Malmhäll, BSc, Sahar Alawieh, BSc, You Lu, PhD,
Prostaglandin E2–EP3 signaling suppresses skin inflammation in murine contact hypersensitivity  Tetsuya Honda, MD, PhD, Toshiyuki Matsuoka, MD, PhD, Mayumi.
Repeated low-dose intradermal allergen injection suppresses allergen-induced cutaneous late responses  Giuseppina Rotiroti, MD, Mohamed Shamji, PhD, Stephen.
Placental transfer of allergen-specific IgG but not IgE from a specific immunotherapy– treated mother  Sabine Flicker, PhD, Katharina Marth, MD, Heinz.
Soybean isoflavones regulate dendritic cell function and suppress allergic sensitization to peanut  Madhan Masilamani, PhD, John Wei, BA, Shiven Bhatt,
Possible new therapeutic strategy to regulate atopic dermatitis through upregulating filaggrin expression  Atsushi Otsuka, MD, PhD, Hiromi Doi, MS, Gyohei.
Systemic responses after bronchial aspirin challenge in sensitive patients with asthma  Joanna S. Makowska, MD, PhD, Janina Grzegorczyk, PhD, Barbara Bienkiewicz,
TNF can contribute to multiple features of ovalbumin-induced allergic inflammation of the airways in mice  Susumu Nakae, PhD, Carolina Lunderius, PhD,
Presentation transcript:

Prostaglandin E receptor subtype EP3 in conjunctival epithelium regulates late-phase reaction of experimental allergic conjunctivitis  Mayumi Ueta, MD, PhD, Toshiyuki Matsuoka, MD, PhD, Shuh Narumiya, MD, PhD, Shigeru Kinoshita, MD, PhD  Journal of Allergy and Clinical Immunology  Volume 123, Issue 2, Pages 466-471.e5 (February 2009) DOI: 10.1016/j.jaci.2008.09.044 Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Expression and localization of EP3 in the conjunctiva and cornea. A, RT-PCR analyses of the expression of EP3-specific mRNA in the cornea and conjunctiva of wild-type mice. B, Histochemical staining for EP3 (X-gal): wild-type mice (a) and Ptger3−/− mice (b-d). Data are representative of 3 experiments. C, Immunohistologic analysis for EP3. Each bar represents a length of 500 (B, a, b), 50 (B, c, d), or 100 (C) μm. Data are representative of 3 experiments. ∗Conjunctival epithelium, #corneal epithelium, ∋Corneal endothelium. Journal of Allergy and Clinical Immunology 2009 123, 466-471.e5DOI: (10.1016/j.jaci.2008.09.044) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Histologic analyses of eosinophil inflammation in conjunctiva. Infiltration of eosinophils into the conjunctiva of wild-type and Ptger3−/− mice were detected by using the Luna method, which stained eosinophil granules with a distinctive red. Scale bars = 50 μm. Journal of Allergy and Clinical Immunology 2009 123, 466-471.e5DOI: (10.1016/j.jaci.2008.09.044) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 3 Real-time PCR analyses of the expression of eotaxin-1 mRNA in the eyelids 6 hours after RW challenge. Relative mRNA expression levels for eotaxin-1 normalized by GAPDH are shown. Data are shown as the mean ± SEM of 7 samples per group. ∗P < .05. Journal of Allergy and Clinical Immunology 2009 123, 466-471.e5DOI: (10.1016/j.jaci.2008.09.044) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 4 RW challenge increased PGE2 synthesis in eyelids. A, Time course of COX-2 and mPGES-1 mRNA expression in eyelids during EAC. The y-axis shows the increase of specific mRNA over that seen in 0-hour samples. The x-axis shows the time after the RW challenge. Data are shown as the mean ± SEM of 3 samples. B, Time course of PGE2 content in eyelids during EAC. The x-axis shows the time after the RW challenge. Data are shown as the mean ± SEM of 4 samples. C, Localization of mPGES-1 on the ocular surface. Each bar represents a length of 100 μm. Journal of Allergy and Clinical Immunology 2009 123, 466-471.e5DOI: (10.1016/j.jaci.2008.09.044) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 5 The effects of an EP3-selective agonist on eosinophil infiltration in conjunctiva. Data are shown as the mean ± SEM of samples from all the mice examined. Negative control (RW sensitization without challenge), positive control (RW sensitization with challenge) only vehicle, and AE248 are shown. (Wild-type mice: negative control, n = 20; positive control, n = 20; vehicle only, n = 25; AE248, n = 30; Ptger3−/− mice: negative control, n = 11; positive control, n = 11; vehicle only, n = 14; AE248, n = 16). ∗∗∗∗∗P < .0005. Journal of Allergy and Clinical Immunology 2009 123, 466-471.e5DOI: (10.1016/j.jaci.2008.09.044) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Antibody responses to RW sensitization and challenge Antibody responses to RW sensitization and challenge. The serum concentration of total IgE (left) and the log titer of RW-specific IgE (middle) and RW-specific IgG1 (right) assessed by means of ELISA are shown. Sera were prepared from sensitized wild-type and Ptger3−/− mice at 24 hours after RW challenge. Sera from unsensitized wild-type mice were used as controls. Data are shown as the means ± SEMs of 8 samples. Journal of Allergy and Clinical Immunology 2009 123, 466-471.e5DOI: (10.1016/j.jaci.2008.09.044) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

The optimal dose of ONO-AE-248 The optimal dose of ONO-AE-248. ONO-AE-248 was administered at various doses (0.01 ng, 0.1, 1, 10, 100 ng) in 5 μL of PBS per eye to wild-type mice at 1, 3, and 7 hours after RW challenge. The quantified eosinophil numbers in conjunctivas of wild-type mice were shown. The data from the mice without both RW challenge and topical treatment and the mice without topical treatment were used as negative and positive controls, respectively. Data are shown as the means ± SEMs of samples from all mice examined. Positive control (RW sensitization with challenge), n = 19; negative control (RW sensitization without challenge), n = 19. AE248: 0.01 ng, n = 18; 0.1 ng, n = 6; 1 ng, n = 27; 10 ng, n = 6; 100 ng, n = 17. Journal of Allergy and Clinical Immunology 2009 123, 466-471.e5DOI: (10.1016/j.jaci.2008.09.044) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Infiltration of eosinophils into the conjunctiva treated with an EP3-selective agonist. Infiltrations of eosinophils were detected by using the Luna method, which stained eosinophil granules with a distinctive red. Scale bars = 50 μm. Journal of Allergy and Clinical Immunology 2009 123, 466-471.e5DOI: (10.1016/j.jaci.2008.09.044) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

The expression of EP3 in human conjunctival epithelium The expression of EP3 in human conjunctival epithelium. A, RT-PCR analyses of the expression of EP3-specific mRNA. GAPDH, Glyceraldehyde-3-phosphate dehydrogenase. B, Immunohistologic analysis for EP3. Each bar represents a length of 50 μm. Journal of Allergy and Clinical Immunology 2009 123, 466-471.e5DOI: (10.1016/j.jaci.2008.09.044) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions